共 50 条
- [41] Response assessment using 68 Gallium (68Ga) Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography - Computed Tomography (PT/CT) inpatients with oligometastatic prostate cancer undergoing Stereotactic Body Radiotherapy (SBRT) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E572 - E573
- [43] Diagnostic Performance of 68Ga-PSMA-11 Positron Emission Tomography/Computed Tomography to Monitor Treatment Response in Patients with Metastatic Prostate Cancer: The Concordance Between Biochemical Response and Prostate-specific Membrane Antigen Results EUROPEAN UROLOGY FOCUS, 2023, 9 (05): : 832 - 837
- [47] Mapping of Local Recurrences After Radical Prostatectomy Using 68-Gallium-Prostate- Specific Membrane Antigen Positron Emission Tomography/Computed Tomography : Implications for Postprostatectomy Radiation Therapy Clinical Target Volumes INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 115 (01): : 106 - 117
- [49] Clinical Usefulness of Prostate-specific Membrane Antigen-ligand Positron Emission Tomography/Computed Tomography for the Detection of Prostate Cancer Biochemical Recurrence after Primary Radiation Therapy in Patients with Prostate-specific Antigen Below the Phoenix Threshold: Systematic Review and Meta-analysis CLINICAL ONCOLOGY, 2023, 35 (12) : E676 - E688
- [50] Development and External Validation of a Novel Nomogram to Predict the Probability of Pelvic Lymph-node Metastases in Prostate Cancer Patients Using Magnetic Resonance Imaging and Molecular Imaging with Prostate-specific Membrane Antigen Positron Emission Tomography EUROPEAN UROLOGY ONCOLOGY, 2023, 6 (06): : 553 - 563